GIST-话题@MedSci

#GIST#

122篇内容 | 3039人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1455183, encodeId=84c7145518314, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=Clin Cancer Res: KIT外显子9突变的GIST患者接受辅助伊马替尼治疗的疗效：欧洲多中心回顾性研究, objectType=article, longId=218389, objectId=dae121838997, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dae121838997, replyNumber=0, likeNumber=100, createdTime=2021-10-12, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dae121838997, moduleTitle=Clin Cancer Res: KIT外显子9突变的GIST患者接受辅助伊马替尼治疗的疗效：欧洲多中心回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dae121838997)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455182, encodeId=2f36145518289, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比, objectType=article, longId=218080, objectId=e0d821808039, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0d821808039, replyNumber=0, likeNumber=70, createdTime=2021-10-05, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0d821808039, moduleTitle=The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0d821808039)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455181, encodeId=52e51455181a0, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist：女性乳腺癌患者伴有无症状和有症状脑转移的治疗模式和预后：单中心回顾性研究, objectType=article, longId=217620, objectId=08e821e62090, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08e821e62090, replyNumber=0, likeNumber=69, createdTime=2021-09-26, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08e821e62090, moduleTitle=The Oncologist：女性乳腺癌患者伴有无症状和有症状脑转移的治疗模式和预后：单中心回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08e821e62090)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455180, encodeId=9000145518016, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=Oncologist:阿拉伯女性乳腺癌患者体细胞突变的分子谱和频率模式, objectType=article, longId=215847, objectId=144821584ebd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=144821584ebd, replyNumber=0, likeNumber=0, createdTime=2021-08-18, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=144821584ebd, moduleTitle=Oncologist:阿拉伯女性乳腺癌患者体细胞突变的分子谱和频率模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=144821584ebd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455179, encodeId=58b914551e902, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=Oncologist:老年侵袭性非霍奇金淋巴瘤（NHL）的临床结局、治疗毒性和医疗保健利用, objectType=article, longId=215721, objectId=057f215e217a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=057f215e217a, replyNumber=0, likeNumber=60, createdTime=2021-08-15, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=057f215e217a, moduleTitle=Oncologist:老年侵袭性非霍奇金淋巴瘤（NHL）的临床结局、治疗毒性和医疗保健利用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=057f215e217a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455178, encodeId=a41914551e8cf, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=Graphpad Prism 怎么做 logistic回归统计分析？, objectType=article, longId=215639, objectId=2aec215639d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2aec215639d6, replyNumber=0, likeNumber=78, createdTime=2021-08-14, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2aec215639d6, moduleTitle=Graphpad Prism 怎么做 logistic回归统计分析？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2aec215639d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455177, encodeId=283d14551e796, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist：在使用免疫检查点抑制剂治疗的晚期尿路上皮癌患者中，身体成分可作为独立的预测和预后标志物, objectType=article, longId=215463, objectId=64ca21546318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ca21546318, replyNumber=0, likeNumber=117, createdTime=2021-08-10, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ca21546318, moduleTitle=The Oncologist：在使用免疫检查点抑制剂治疗的晚期尿路上皮癌患者中，身体成分可作为独立的预测和预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ca21546318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455176, encodeId=25ca14551e608, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist：免疫治疗治疗转移性非小细胞肺癌的疗效：中东欧国家的真实世界数据, objectType=article, longId=215462, objectId=f5b321546205, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5b321546205, replyNumber=0, likeNumber=134, createdTime=2021-08-10, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5b321546205, moduleTitle=The Oncologist：免疫治疗治疗转移性非小细胞肺癌的疗效：中东欧国家的真实世界数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5b321546205)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455175, encodeId=175814551e51a, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist：转移性尿路上皮癌铂类为基础化疗进展后再挑战的疗效, objectType=article, longId=215461, objectId=9370215461b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9370215461b2, replyNumber=0, likeNumber=85, createdTime=2021-08-10, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9370215461b2, moduleTitle=The Oncologist：转移性尿路上皮癌铂类为基础化疗进展后再挑战的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9370215461b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455174, encodeId=097b14551e4d0, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist：中国胃癌患者不同HER2状态的治疗模式和预后:一项非干预注册研究(EVIDENCE), objectType=article, longId=215442, objectId=6f38215442ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f38215442ba, replyNumber=0, likeNumber=79, createdTime=2021-08-09, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f38215442ba, moduleTitle=The Oncologist：中国胃癌患者不同HER2状态的治疗模式和预后:一项非干预注册研究(EVIDENCE), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f38215442ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455173, encodeId=6e9914551e3a1, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=用SPSS玩转多元logistic回归分析, objectType=article, longId=213039, objectId=37b7213039cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37b7213039cd, replyNumber=0, likeNumber=72, createdTime=2021-06-23, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37b7213039cd, moduleTitle=用SPSS玩转多元logistic回归分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37b7213039cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455172, encodeId=239814551e20f, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist：Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌的安全性分析：来自PALOMA系列5年随访综合分析更新, objectType=article, longId=211389, objectId=ad602113894a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad602113894a, replyNumber=0, likeNumber=59, createdTime=2021-05-17, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad602113894a, moduleTitle=The Oncologist：Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌的安全性分析：来自PALOMA系列5年随访综合分析更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad602113894a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455171, encodeId=9c6e14551e156, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=The Oncologist：HER2基因改变与微卫星不稳定（MSI-H）在结直肠腺癌中的关系, objectType=article, longId=211383, objectId=f20e211383bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20e211383bc, replyNumber=0, likeNumber=90, createdTime=2021-05-17, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20e211383bc, moduleTitle=The Oncologist：HER2基因改变与微卫星不稳定（MSI-H）在结直肠腺癌中的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f20e211383bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455170, encodeId=7c1714551e0ad, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=Oncologist：西米普利单抗+放疗+环磷酰胺+GM-CSF治疗复发/转移性头颈部鳞状细胞癌的疗效和安全性, objectType=article, longId=210895, objectId=1c9e21089525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c9e21089525, replyNumber=0, likeNumber=57, createdTime=2021-05-08, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c9e21089525, moduleTitle=Oncologist：西米普利单抗+放疗+环磷酰胺+GM-CSF治疗复发/转移性头颈部鳞状细胞癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c9e21089525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455169, encodeId=41ed145516912, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=胃肠道间质瘤（GIST）的治疗或迎新突破，EMA授予Ilixadencel“孤儿药资格”, objectType=article, longId=207384, objectId=922f20e38487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922f20e38487, replyNumber=0, likeNumber=55, createdTime=2021-02-22, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922f20e38487, moduleTitle=胃肠道间质瘤（GIST）的治疗或迎新突破，EMA授予Ilixadencel“孤儿药资格”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=922f20e38487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455168, encodeId=cb161455168e0, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=Oncologist：Nivolumab加低剂量Ipilimumab为既往治疗的微卫星不稳定及高/错配修复缺陷型转移性结直肠癌患者提供新的治疗选择, objectType=article, longId=201431, objectId=64b22014318f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64b22014318f, replyNumber=0, likeNumber=55, createdTime=2020-10-02, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64b22014318f, moduleTitle=Oncologist：Nivolumab加低剂量Ipilimumab为既往治疗的微卫星不稳定及高/错配修复缺陷型转移性结直肠癌患者提供新的治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64b22014318f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455167, encodeId=09f0145516ef4, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=基于基因分型的精准治疗是胃肠间质瘤GIST治疗的未来发展方向, objectType=article, longId=198224, objectId=2ac91982241c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ac91982241c, replyNumber=0, likeNumber=80, createdTime=2020-07-30, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ac91982241c, moduleTitle=基于基因分型的精准治疗是胃肠间质瘤GIST治疗的未来发展方向, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ac91982241c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455166, encodeId=776c145516629, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度, objectType=article, longId=196135, objectId=1ddd196135a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ddd196135a4, replyNumber=0, likeNumber=85, createdTime=2020-06-21, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ddd196135a4, moduleTitle=曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ddd196135a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455165, encodeId=b699145516535, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=Oncologist：许建民教授发现CERR得分能良好评估结直肠癌肝转移手术后复发状况, objectType=article, longId=194266, objectId=029b19426680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=029b19426680, replyNumber=0, likeNumber=72, createdTime=2020-05-18, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=029b19426680, moduleTitle=Oncologist：许建民教授发现CERR得分能良好评估结直肠癌肝转移手术后复发状况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=029b19426680)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1455164, encodeId=5112145516455, content=<a href='/topic/show?id=bebe8032fc' target=_blank style='color:#2F92EE;'>#GIST#</a>, objectTitle=晚期胃肠道间质瘤（GIST）患者的新希望！四线疗法Ripretinib获FDA批准, objectType=article, longId=194259, objectId=741619425993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=741619425993, replyNumber=0, likeNumber=0, createdTime=2020-05-18, rootId=0, userName=july_977, userId=6e445632366, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=741619425993, moduleTitle=晚期胃肠道间质瘤（GIST）患者的新希望！四线疗法Ripretinib获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=741619425993)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

GIST

2020-05-29

july_977 (审核中...)

前往app查看评论内容

#GIST#

Clin Cancer Res: KIT外显子9突变的GIST患者接受辅助伊马替尼治疗的疗效：欧洲多中心回顾性研究

2021-10-12

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist： FTD/TPI和瑞戈非尼治疗晚期结直肠癌患者疗效对比

2021-10-05

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist：女性乳腺癌患者伴有无症状和有症状脑转移的治疗模式和预后：单中心回顾性研究

2021-09-26

july_977 (审核中...)

前往app查看评论内容

#GIST#

Oncologist:阿拉伯女性乳腺癌患者体细胞突变的分子谱和频率模式

2021-08-18

july_977 (审核中...)

前往app查看评论内容

#GIST#

Oncologist:老年侵袭性非霍奇金淋巴瘤（NHL）的临床结局、治疗毒性和医疗保健利用

2021-08-15

july_977 (审核中...)

前往app查看评论内容

#GIST#

Graphpad Prism 怎么做 logistic回归统计分析？

2021-08-14

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist：在使用免疫检查点抑制剂治疗的晚期尿路上皮癌患者中，身体成分可作为独立的预测和预后标志物

2021-08-10

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist：免疫治疗治疗转移性非小细胞肺癌的疗效：中东欧国家的真实世界数据

2021-08-10

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist：转移性尿路上皮癌铂类为基础化疗进展后再挑战的疗效

2021-08-10

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist：中国胃癌患者不同HER2状态的治疗模式和预后:一项非干预注册研究(EVIDENCE)

2021-08-09

july_977 (审核中...)

前往app查看评论内容

#GIST#

用SPSS玩转多元logistic回归分析

2021-06-23

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist：Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌的安全性分析：来自PALOMA系列5年随访综合分析更新

2021-05-17

july_977 (审核中...)

前往app查看评论内容

#GIST#

The Oncologist：HER2基因改变与微卫星不稳定（MSI-H）在结直肠腺癌中的关系

2021-05-17

july_977 (审核中...)

前往app查看评论内容

#GIST#

Oncologist：西米普利单抗+放疗+环磷酰胺+GM-CSF治疗复发/转移性头颈部鳞状细胞癌的疗效和安全性

2021-05-08

july_977 (审核中...)

前往app查看评论内容

#GIST#

胃肠道间质瘤（GIST）的治疗或迎新突破，EMA授予Ilixadencel“孤儿药资格”

2021-02-22

july_977 (审核中...)

前往app查看评论内容

#GIST#

Oncologist：Nivolumab加低剂量Ipilimumab为既往治疗的微卫星不稳定及高/错配修复缺陷型转移性结直肠癌患者提供新的治疗选择

2020-10-02

july_977 (审核中...)

前往app查看评论内容

#GIST#

基于基因分型的精准治疗是胃肠间质瘤GIST治疗的未来发展方向

2020-07-30

july_977 (审核中...)

前往app查看评论内容

#GIST#

曹晖教授：Avapritinib力克耐药突变，GIST患者治疗迈向新高度

2020-06-21

july_977 (审核中...)

前往app查看评论内容

#GIST#

Oncologist：许建民教授发现CERR得分能良好评估结直肠癌肝转移手术后复发状况

2020-05-18

july_977 (审核中...)

前往app查看评论内容

#GIST#

晚期胃肠道间质瘤（GIST）患者的新希望！四线疗法Ripretinib获FDA批准

2020-05-18

科室
- - 订阅+
  - 更多科室
工具
服务